leisure time -WSS

leisure time

author：hotspot 2025-10-01 22:49:46 - browse：12

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Eli Lilly reports tirzepatide MASH success during Q4 earnings

leisure time

WSS

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

The FDA must approve intranasal treatments for anaphylaxis

3 trends to watch in health tech's hiring outlook for 2024

Ahead of JPM, here's who's profiting most in health care

Doctors on social media are being harassed and cyberbullied

AMAs digital advisors table RPM coding reform proposal, again

explore

leisure time

focus

Jerome Adams on the need for new antivirals for Covid

How a scoliosis diagnosis changed the life of one young dancer

At least 13 dead in Texas as scorching temps continue

Ebola vaccine can save some who are already sick, per new study

Anesthesiologist group: stop taking Ozempic before surgery

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Affirmative action in medical school literally saved lives

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Medical records are filled with copy

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

knowledge

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Resistance to opioid

UCB departs biotech trade group BIO

Why Eli Lilly’s earnings didn’t quite live up to the hype

A single drug, study failures leave Anavex with nothing but cash

leisure time

leisure time

entertainment

knowledge